TipRanks
Community Health (DE:CG5)
FRANKFURT:CG5
Germany Market

Community Health (CG5) Ratios

1 Followers

Community Health Ratios

DE:CG5's free cash flow for Q2 2026 was $0.70. For the 2026 fiscal year, DE:CG5's free cash flow was decreased by $ and operating cash flow was $0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.53 1.46 1.41 1.50 1.41
Quick Ratio
1.39 1.32 1.27 1.34 1.25
Cash Ratio
0.07 0.12 0.02 0.02 0.05
Solvency Ratio
0.03 0.07 >-0.01 0.02 0.03
Operating Cash Flow Ratio
0.06 0.25 0.20 0.10 0.14
Short-Term Operating Cash Flow Coverage
4.85 4.31 3.56 1.45 1.78
Net Current Asset Value
$ -10.26B$ -10.81B$ -12.07B$ -12.07B$ -12.32B
Leverage Ratios
Debt-to-Assets Ratio
0.84 0.88 0.86 0.84 0.84
Debt-to-Equity Ratio
-7.34 -8.31 -6.32 -8.75 -9.06
Debt-to-Capital Ratio
1.16 1.14 1.19 1.13 1.12
Long-Term Debt-to-Capital Ratio
1.17 1.15 1.21 1.14 1.14
Financial Leverage Ratio
-8.76 -9.47 -7.34 -10.38 -10.73
Debt Service Coverage Ratio
5.49 1.98 1.17 1.13 0.97
Interest Coverage Ratio
-10.14 -11.40 0.63 1.15 0.96
Debt to Market Cap
23.67 25.93 28.80 27.93 20.78
Interest Debt Per Share
81.93 92.91 98.14 99.75 102.83
Net Debt to EBITDA
2.05 5.60 9.66 9.37 10.51
Profitability Margins
Gross Profit Margin
58.08%8.67%41.71%40.69%40.18%
EBIT Margin
18.61%12.77%6.67%6.97%5.89%
EBITDA Margin
21.89%16.18%9.89%10.37%9.57%
Operating Profit Margin
-38.72%-79.42%4.29%7.66%6.72%
Pretax Profit Margin
-2.15%5.80%-2.24%1.66%2.86%
Net Profit Margin
-1.34%4.08%-4.08%-1.06%0.38%
Continuous Operations Profit Margin
-2.44%5.41%-2.87%0.13%1.47%
Net Income Per EBT
62.37%70.30%182.33%-64.25%13.18%
EBT Per EBIT
5.54%-7.30%-52.21%21.63%42.51%
Return on Assets (ROA)
-2.46%3.85%-3.67%-0.92%0.31%
Return on Equity (ROE)
20.91%-36.51%26.96%9.55%-3.37%
Return on Capital Employed (ROCE)
-85.40%-90.17%4.63%7.77%6.58%
Return on Invested Capital (ROIC)
-84.36%-83.24%4.58%0.59%3.33%
Return on Tangible Assets
-3.35%5.22%-5.11%-1.29%0.45%
Earnings Yield
-77.43%121.75%-130.64%-32.59%8.27%
Efficiency Ratios
Receivables Turnover
10.46 5.53 5.16 5.29 5.71
Payables Turnover
13.18 13.54 9.39 9.13 10.65
Inventory Turnover
34.67 35.41 22.25 22.59 20.69
Fixed Asset Turnover
5.36 2.44 2.34 2.13 2.00
Asset Turnover
1.84 0.95 0.90 0.86 0.83
Working Capital Turnover Ratio
19.74 12.60 12.50 12.73 12.14
Cash Conversion Cycle
17.73 49.37 48.24 45.20 47.24
Days of Sales Outstanding
34.90 66.01 70.69 69.00 63.88
Days of Inventory Outstanding
10.53 10.31 16.41 16.16 17.64
Days of Payables Outstanding
27.70 26.95 38.86 39.96 34.28
Operating Cycle
45.43 76.32 87.10 85.16 81.52
Cash Flow Ratios
Operating Cash Flow Per Share
0.93 4.05 3.63 1.61 2.33
Free Cash Flow Per Share
-1.37 1.55 0.91 -1.97 -0.89
CapEx Per Share
2.30 2.50 2.73 3.58 3.22
Free Cash Flow to Operating Cash Flow
-1.47 0.38 0.25 -1.22 -0.38
Dividend Paid and CapEx Coverage Ratio
0.41 1.62 1.33 0.45 0.72
Capital Expenditure Coverage Ratio
0.41 1.62 1.33 0.45 0.72
Operating Cash Flow Coverage Ratio
0.01 0.05 0.04 0.02 0.02
Operating Cash Flow to Sales Ratio
<0.01 0.04 0.04 0.02 0.02
Free Cash Flow Yield
-45.71%49.75%30.38%-62.97%-20.67%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-1.27 0.82 -0.77 -3.07 12.10
Price-to-Sales (P/S) Ratio
0.02 0.03 0.03 0.03 0.05
Price-to-Book (P/B) Ratio
-0.28 -0.30 -0.21 -0.29 -0.41
Price-to-Free Cash Flow (P/FCF) Ratio
-2.19 2.01 3.29 -1.59 -4.84
Price-to-Operating Cash Flow Ratio
3.08 0.77 0.82 1.94 1.85
Price-to-Earnings Growth (PEG) Ratio
-0.03 >-0.01 >-0.01 <0.01 -0.15
Price-to-Fair Value
-0.28 -0.30 -0.21 -0.29 -0.41
Enterprise Value Multiple
2.13 5.81 9.98 9.69 10.98
Enterprise Value
10.46B 11.74B 12.46B 12.54B 12.83B
EV to EBITDA
2.13 5.81 9.98 9.69 10.98
EV to Sales
0.47 0.94 0.99 1.00 1.05
EV to Free Cash Flow
-56.54 56.43 103.83 -48.81 -111.53
EV to Operating Cash Flow
83.02 21.62 25.96 59.73 42.75
Tangible Book Value Per Share
-32.53 -32.07 -39.95 -38.25 -39.78
Shareholders’ Equity Per Share
-10.30 -10.40 -14.49 -10.68 -10.61
Tax and Other Ratios
Effective Tax Rate
-0.14 0.07 -0.28 0.92 0.49
Revenue Per Share
166.02 93.17 95.64 95.79 94.80
Net Income Per Share
-2.22 3.80 -3.91 -1.02 0.36
Tax Burden
0.62 0.70 1.82 -0.64 0.13
Interest Burden
-0.12 0.45 -0.34 0.24 0.49
Research & Development to Revenue
0.00 0.00 0.00 <0.01 <0.01
SG&A to Revenue
0.53 0.00 0.02 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 <0.01 0.00 0.00 0.00
Income Quality
0.44 0.80 -0.93 -1.58 6.52
Currency in USD